The Use of a Quality of Life Questionnaire in Patients With Lung Cancer

NCT01213745 | Unknown

• 1 other identifier: CCR3454
• Study Type: interventional
• Target: 138
• Locations: 1 country
• Sites: 1

Brief Summary

This study will investigate the effectiveness of using the European Organisation for Research and Treatment of cancer Core Quality of Life Questionnaire (EORTC QLQ-C30 + LC 13) to identify and target therapies in patients with lung cancer. The study will assess whether using the questionnaire will result in an improvement in QoL.

Conditions

Lung Cancer

Keywords

lung; cancer; quality of life

Outcome Measures

Primary Outcomes (1)

• To investigate whether the use of QOL questionnaires during the assessment and management of lung cancer patients results in improved quality of life

Secondary Outcomes (1)

• To investigate whether the use of EORTC QLQ-C30 + lung cancer module results in less patient contact with health care professionals during the 6 week study period for the 3 groups

Study Arms (3)

Intervention

EXPERIMENTAL

Other: Intervention

Attention

EXPERIMENTAL

Other: Attention

Control

ACTIVE COMPARATOR

Other: Control

Interventions

Intervention OTHER

Intervention

Attention OTHER

Attention

Control OTHER

Control

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• male or female age \> 18 years
• patients who are able to adequately understand written and spoken english
• diagnosis of lung cancer (non small cell, small cell, mesothelioma)
• no plan to commence treatment (chemotheraphy, targeted therapies, radioterhapy, surgery) with 6 weeks
• both radically or palliatively treated patients remain eligible
• patients whose toxicities from their primary treatment has resolved or have stabilised for a period of 7 days

You may not qualify if:

• patients are taking part on any other QoL studies
• taking part in any other studies that requires QoL questionnaires, extra visits or investigations
• currently on treatment (chemotherapy, radiotherapy, surgery or targeted therapies)
• they have on going toxicities from their treatment which have not been stablised (required intervention within last 7 days)

Sponsors & Collaborators

• Royal Marsden NHS Foundation Trust: lead

Study Sites (1)

Royal Marsden NHS Foundation Trust

Sutton, SM2 5PT, United Kingdom

RECRUITING

Related Publications (1)

• Nimako K, Ayite B, Priest K, Severn J, Fries HM, Gunapala R, Bhosle J, Popat S, O'Brien M. A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic. Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12402. Epub 2015 Nov 10.

  PMID: 26556778 DERIVED

MeSH Terms

Conditions

Lung Neoplasms; Neoplasms

Interventions

Methods; Neuropsychological Tests

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques; Psychological Tests; Behavioral Disciplines and Activities

Study Officials

• Dr M O'Brien

  Royal Marsden NHS Foundation Trust

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr M O'Brien

CONTACT

02086613278; mary.o'brien@rmh.nhs.uk

Mr M Laybourne

CONTACT

02086613835; matthew.laybourne@rmh.nhs.uk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: October 1, 2010
• First Posted: October 4, 2010
• Study Start: September 1, 2010
• Primary Completion: July 1, 2012
• Study Completion: July 1, 2012
• Last Updated: October 21, 2010

Record last verified: 2010-10

Locations

GB (1)